Oncology Precision Medicine Market Is Anticipated To Witness High Growth Owing To Increasing Prevalence Of Cancer

 


Oncology precision medicine involves the use of pharmaceuticals and tests that target specific abnormalities within cancer cells in order to improve treatment effectiveness and reduce treatment related side-effects. The growth in demand for non-invasive and precise cancer treatment options drives the market. Personalized treatment through precision medicine takes into account an individual patient's genes, lifestyle and environment to determine the best treatment approach.

The Oncology Precision Medicine Market is estimated to be valued at US$ 130 Bn in 2024 and is expected to exhibit a CAGR of 8.9% over the forecast period 2024-2031.

Key Takeaways

Key players operating in the Oncology Precision Medicine are AstraZeneca, Novartis, Pfizer, Bristol-Myers Squibb, and Roche. These key players are actively focusing on the development of advanced diagnostics and targeted therapies for different types of cancers.

Some of the key opportunities in the market include expanding targeted therapy options for various types of cancers and development of combination therapies. Companies are also investing in clinical studies to evaluate efficacy of precision medicines for hard-to-treat cancers.

Global expansion in emerging markets through strategic partnerships is a major focus area for key players. Companies are expanding presence in Asia Pacific and Latin America region through collaborations with regional diagnostic players and healthcare providers to drive volume-based sales.

Market Drivers

Increasing prevalence of cancer worldwide is a major market driver. According to WHO, global cancer burden is expected to rise to 27.5 million new cancer cases and 16.3 million cancer deaths by 2040. Growing demand for non-toxic targeted treatment options contributes to the market growth.

Market Restrains

High cost of precision medicines and companion diagnostics poses significant affordability challenges in developing regions. Limited awareness regarding benefits of precision medicine in developing countries also restrains the market growth.

Segment Analysis

The oncology precision medicine market has following major segments - Lung Cancer, Breast Cancer, Colorectal cancer, Prostate cancer, Blood Cancer. Among these, Lung cancer segment dominates the market currently. This is because lung cancer is the leading cause of cancer death worldwide. Genetic changes like abnormalities in the EGFR, ALK have helped in developing targeted therapies for non-small cell lung cancer, which is the most common type of lung cancer. Precision medicines like Iressa, Tarceva, Tagrisso help in better management of lung cancer.

Global Analysis

North America region holds the highest share in oncology precision medicine market currently. This is due to rising prevalence of cancer, growing awareness about precision medicine approach and well developed healthcare infrastructure. Various research studies and availability of funding for research also contributes to the growth of the market. Asia Pacific is expected to witness highest growth during the forecast period due to rising healthcare spending, increasing disposable income, growing cancer burden especially in China and India. Initiatives by governments in countries like China to develop precision medicine capabilities will boost the market in the region. Europe also holds significant share due to presence of major pharma companies and supportive regulatory environment for precision therapies.

Get more insights on this topic:  https://www.newsanalyticspro.com/oncology-precision-medicine-market-is-estimated-to-witness-high-growth-owing-to-personalized-treatment-approaches/

 

Author Bio:

Alice Mutum is a seasoned senior content editor at Coherent Market Insights, leveraging extensive expertise gained from her previous role as a content writer. With seven years in content development, Alice masterfully employs SEO best practices and cutting-edge digital marketing strategies to craft high-ranking, impactful content. As an editor, she meticulously ensures flawless grammar and punctuation, precise data accuracy, and perfect alignment with audience needs in every research report. Alice's dedication to excellence and her strategic approach to content make her an invaluable asset in the world of market insights. (LinkedIn: www.linkedin.com/in/alice-mutum-3b247b137 )

What Are The Key Data Covered In This Oncology Precision Medicine  Market Report?

:- Market CAGR throughout the predicted period

:- Comprehensive information on the aspects that will drive the Oncology Precision Medicine 's growth between 2024 and 2031.

:- Accurate calculation of the size of the Oncology Precision Medicine  and its contribution to the market, with emphasis on the parent market

:- Realistic forecasts of future trends and changes in consumer behaviour

:- Oncology Precision Medicine  Industry Growth in North America, APAC, Europe, South America, the Middle East, and Africa

:- A complete examination of the market's competitive landscape, as well as extensive information on vendors

:- Detailed examination of the factors that will impede the expansion of Oncology Precision Medicine  vendors

FAQ’s

Q.1 What are the main factors influencing the Oncology Precision Medicine ?

Q.2 Which companies are the major sources in this industry?

Q.3 What are the market’s opportunities, risks, and general structure?

Q.4 Which of the top Oncology Precision Medicine  companies compare in terms of sales, revenue, and prices?

Q.5 Which businesses serve as the Oncology Precision Medicine ’s distributors, traders, and dealers?

Q.6 How are market types and applications and deals, revenue, and value explored?

Q.7 What does a business area’s assessment of agreements, income, and value implicate?

*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it

Comments

Post a Comment

Popular posts from this blog

United States Candy : A Sweet Tradition

Image
Candy making has deep roots in American history dating back to the colonial period. Some of the earliest candy recipes originated from European immigrants who brought their candy traditions with them. Traditional candy recipes from Britain, France, Italy, and the Netherlands were adapted to ingredients available in North America. Early American colonists produced homemade candies, often using maple syrup or sorghum as a sweetener before cane sugar was widely available. In the 1800s, candy shops in large cities began commercial production of sweets. Famous US candy brands emerged in the later 19th century as machinery allowed for mass production. Brands like Brach's, Cracker Jack, and Tootsie Roll got their start during this time period and are still going strong today. Candy was also becoming more affordable and accessible for the average American consumer. Chocolate Dominates   Chocolate is by far the biggest selling candy category in the United States Candy  today. C...
Read more

United Kingdom Pelargonic Acid : Pelargonic Acid Dynamics In The United Kingdom

Image
The United Kingdom has seen steady growth in the production and consumption of pelargonic acid over the past decade. Pelargonic acid, also known as nonanoic acid, is a saturated fatty acid found in several plant and animal sources. Some of the key production and consumption trends for pelargonic acid in the UK are: - Domestic production of pelargonic acid in the UK has increased at a compound annual growth rate of around 5% since 2010. The country currently has an annual United Kingdom Pelargonic Acid production capacity of over 45,000 metric tons. - Major producers in the UK include CREMER, Wilmar, and Oleon. CREMER operates the largest pelargonic acid production plant in Europe located in Barry, Wales with a capacity of 25,000 metric tons per year. - Consumption of pelargonic acid has grown at a similar pace to production. The compound finds key applications in fragrances, lubricants, plasticizers, and antimicrobial formulations in the country. - Fragrances remain the dominant e...
Read more

United Kingdom Gas Leak Detector : Ensuring Safety In Homes And Businesses

Image
There are different types of gas leak detectors used in the United Kingdom to detect potentially dangerous leaks from gas appliances, pipes, valves and other components. The most common types include: - Sensor-based detectors: These contain sensors that can detect combustible or toxic gases like methane, propane and natural gas. When gas is sensed, an audible alarm activates to alert users. Some advanced models have digital displays to show the type and concentration of gas. - Soap solution detectors: A simple but effective option, these contain a soap solution inside a small container or spray bottle. Users spray the solution onto suspected leak areas and watch for bubbles, which indicate a leak. United Kingdom Gas Leak Detector Soap solution detectors are inexpensive but not as precise as electronic options. - Infrared cameras: Specialized infrared cameras can detect invisible gas leaks by sensing the infrared radiation emitted by the gases. These high-tech devices provide vis...
Read more